Tennessee Senate Bill SB0331

Tennessee 2025-2026 Regular Session

• Introduced: 1/27/25

Caption

AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 14; Title 29; Title 33; Title 37; Title 39; Title 53; Title 63; Title 68 and Title 71, relative to health care.

Summary

SB0331 is a narrow administrative health care bill. It amends Tennessee Code Annotated section 68-1-806 by changing a statutory deadline from March 1 to January 15. The bill does not create a new program, benefit, or regulatory scheme; instead, it accelerates an existing reporting or filing deadline tied to the health care provisions in Title 68. Because the bill only changes one date in the code, its legal effect is limited but concrete: any person, entity, or agency subject to section 68-1-806 would need to comply earlier in the calendar year. The bill takes effect immediately upon becoming law, reflecting a desire for prompt implementation.

Impact

The bill amends a single provision in Tennessee’s health care statutes, specifically Tennessee Code Annotated section 68-1-806, by moving a deadline from March 1 to January 15. This changes the timing of whatever filing, notice, or administrative action is required under that section, but it does not otherwise alter substantive rights, duties, or enforcement mechanisms. The practical impact is to require affected parties and administering agencies to act sooner each year.

Sentiment

There is little visible controversy or debate in the available record. The bill’s text is brief and technical, and there are no committee transcripts or recorded votes provided to indicate opposition or strong advocacy. The overall sentiment appears neutral to favorable, consistent with a housekeeping-style amendment intended to improve or expedite administrative timing.

Contention

No specific points of contention are documented in the available materials. The only potentially debatable issue is the earlier deadline itself, which could impose a tighter compliance schedule on regulated parties or administrative agencies. However, without committee discussion or vote data, there is no evidence of organized opposition, and no particular stakeholder group is identified as objecting.